Save up to 90% on Namzaric with Coupons, Discount Cards & Patient Assistance Programs

Namzaric is the brand name for memantine hydrochloride extended-release and donepezil in an oral capsule.

Namzaric is available as an oral capsule that contains one of the following:

• 14 mg memantine hydrochloride extended-release and 10 mg donepezil hydrochloride
• 28 mg memantine hydrochloride extended-release and 10 mg donepezil hydrochloride

Namzaric is a NMDA antagonist / Acetylcholinesterase inhibitor and is used to treat moderate-to-severe dementia in people with Alzheimer’s disease (AD).

Namzaric is a combination of two medications that treats moderate-to-severe dementia in people with Alzheimer’s disease. Memantine (an NMDA antagonist) lowers the activity of certain proteins in your brain. Donepezil (an acetylcholinesterase inhibitor) raises the levels of acetylcholine in the brain. These two medications work together to lower the symptoms of Alzheimer’s.

Namzaric is dosed as follows:

• If your condition is stable on donepezil only: The typical starting dose is 7 mg/10 mg (memantine/donepezil) by mouth once per day in the evening. Your dose will be slowly raised in 7 mg increments until you reach 28 mg/10 mg (memantine/donepezil) once per day
• If your condition is stable on both donepezil and memantine (separately): The typical starting dose is 28 mg/10 mg (memantine/donepezil) by mouth once per day in the evening

Your dose may differ if you have kidney problems.

Namzaric is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you. Namzaric is contraindicated in patients with known hypersensitivity to
memantine hydrochloride, donepezil hydrochloride, piperidine derivatives, or to any excipients used in the formulation.

Common side effects of Namzaric:

• Headache
• Diarrhea
• Nausea
• Vomiting
• Dizziness
• Loss of appetite (anorexia)
• Bruising

Serious side effects are rare with Namzaric. Contact your healthcare provider immediately if you experience any of the following.

• Chest pain
• Seizure
• Slow heartbeat: fainting
• Stomach ulcers and bleeding: worsening upset stomach, heartburn, indigestion

The following medications may interact with Namzaric:

• Combined use with NMDA antagonists: use with caution.
• Namzaric may interfere with anticholinergic medications
• Concomitant administration of succinylcholine, similar neuromuscular blocking agents, or cholinergic agonists may lead to synergistic effect

Forest Pharmaceuticals, Inc.

It is not known if Namzaric can harm an unborn baby. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

• Memantine /Donepezil